Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Capital Expenditures (2019 - 2025)

Historic Capital Expenditures for Volitionrx (VNRX) over the last 9 years, with Q2 2025 value amounting to $76783.0.

  • Volitionrx's Capital Expenditures rose 32279.06% to $76783.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $170046.0, marking a year-over-year decrease of 6689.26%. This contributed to the annual value of $296353.0 for FY2024, which is 7265.48% down from last year.
  • Per Volitionrx's latest filing, its Capital Expenditures stood at $76783.0 for Q2 2025, which was up 32279.06% from $1808.0 recorded in Q1 2025.
  • In the past 5 years, Volitionrx's Capital Expenditures registered a high of $578752.0 during Q4 2022, and its lowest value of $1808.0 during Q1 2025.
  • Its 5-year average for Capital Expenditures is $222357.4, with a median of $171199.5 in 2021.
  • Per our database at Business Quant, Volitionrx's Capital Expenditures surged by 35013.84% in 2022 and then tumbled by 9638.4% in 2025.
  • Over the past 5 years, Volitionrx's Capital Expenditures (Quarter) stood at $128572.0 in 2021, then skyrocketed by 350.14% to $578752.0 in 2022, then tumbled by 46.66% to $308722.0 in 2023, then plummeted by 70.38% to $91455.0 in 2024, then fell by 16.04% to $76783.0 in 2025.
  • Its last three reported values are $76783.0 in Q2 2025, $1808.0 for Q1 2025, and $91455.0 during Q4 2024.